Safer Medications for Children and Youth

Last modified by Ann Watkins on 2019/08/15 16:00

Children, like adults, have a right to the highest attainable standard of health, which includes the appropriate treatment of disease.  Yet children and youth continue to be under-represented in medication research, as well as the design of medication-related regulations and commercial medication development.

Up to 80% of all medications currently prescribed in Canadian paediatric hospital settings are administered off-label, meaning that the use deviates from the dose, route of administration, patient age and or medical indication in the Health Canada-approved monograph.  Moreover, many commonly prescribed pediatric medications cannot be dispensed as commercially available child-friendly formulations (i.e. a liquid or a low-dose mini-tab). Both practices are associated with significant risk, including adverse events, safety issues and efficacy concerns for children and youth.

This webinar will provide an in-depth overview of the current state of Pediatric Medications in Canada.  Panelists will discuss access barriers, opportunities such as a National Pharmacare Plan as well as recommendations regarding pediatric drug research and the drug regulatory system in Canada.  Advocating to improve the health outcomes of children and youth is imperative, please join the discussion.

Click here to register for the webinar on September 25, 2018 at 11am ET.

Presenter bios to be posted shortly.

Created by Ann Watkins on 2019/08/15 15:57